Topics

STAT Plus: Pharmalittle: Sackler role in opioid crisis to be debated in court; J&J legal strategy shows risks

09:44 EDT 11 Oct 2019 | STAT

A jury award that hit Johnson & Johnson with $8 billion in punitive damages for a case involving its Risperdal anti-psychotic drug highlights the risks of its all-or-nothing legal strategy.

Original Article: STAT Plus: Pharmalittle: Sackler role in opioid crisis to be debated in court; J&J legal strategy shows risks

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: Sackler role in opioid crisis to be debated in court; J&J legal strategy shows risks"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...